Post-PBAC Listing Times For High-Cost Medicines Have Improved Under The MoU - Pradaxa The Except

New Stories

• The 'Dispatched' Podcast - Series 5, Ep.25

  July 24, 2026 - - Podcast

• Finalists named for the 2026 Patient's Choice awards

  July 24, 2026 - - Latest News

• Australian company moving headquarters to US and restructuring workforce

  July 24, 2026 - - Latest News

• The 'end of days' language is just a farcical attempt to shut down discussion

  July 24, 2026 - - Latest News

• How national HPV vaccination programs are changing the story of cervical cancer

  July 23, 2026 - - Latest News

• Faster processes could push Pharmac's options for investment backlog to 400 within two years

  July 23, 2026 - - Latest News

• Bellberry and ASCEPT release checklist for 'new approach methodologies' trials

  July 23, 2026 - - Latest News